Publications by authors named "D Fina"

Objectives: Post-acute myocardial infarction mechanical complications (post-AMI MCs) represent rare but life-threatening conditions, including free-wall rupture, ventricular septal rupture and papillary muscle rupture. During the coronavirus disease-19 (COVID-19) pandemic, an overwhelming pressure on healthcare systems led to delayed and potentially suboptimal treatments for time-dependent conditions. As AMI-related hospitalizations decreased, limited information is available whether higher rates of post-AMI MCs and related deaths occurred in this setting.

View Article and Find Full Text PDF

: Platelet count reduction (PR) is a common but unclear phenomenon that occurs after aortic bioprosthesis valve implantation (bio-AVR). This study aimed to investigate the occurrence and clinical impact of PR in patients receiving stented, rapid deployment (RDV), or stentless bioprostheses. : 1233 adult bio-AVR patients were enrolled.

View Article and Find Full Text PDF
Article Synopsis
  • Routine use of topical vancomycin after cardiac surgery is often overlooked, despite it being recommended in guidelines and questioned in recent trials for its effectiveness against sternal wound infections.
  • An analysis of 20 studies, including both randomized controlled trials and observational studies, showed that topical vancomycin reduced the risk of sternal wound infections by nearly 70%, with benefits seen for both superficial and deep infections.
  • The treatment's effectiveness was particularly pronounced in patients with diabetes, and no resistance to vancomycin or methicillin was found, leading to a significant decrease in gram-negative cultures as well.
View Article and Find Full Text PDF
Article Synopsis
  • Transcatheter aortic valve implantation (TAVI) is an alternative to traditional surgery for patients with aortic stenosis, with new valve designs like Medtronic's Evolut PRO aiming to improve patient outcomes.
  • A systematic review and meta-analysis compared the new Evolut PRO valve with its predecessor, the Evolut R, using data from 11 studies involving over 12,000 patients.
  • Findings revealed that both valves had similar overall outcomes, but the Evolut PRO significantly reduced the risk of moderate-to-severe paravalvular leaks and major bleeding compared to the Evolut R.
View Article and Find Full Text PDF

Objectives: Although endorsed by international guidelines, complete revascularization (CR) with Coronary Artery Bypass Grafting (CABG) remains underused. In higher-risk patients such as those with pre-operative atrial fibrillation (AF), the effects of CR are not well studied.

Methods: We analyzed patients' data from the HEIST (HEart surgery In AF and Supraventricular Tachycardia) registry.

View Article and Find Full Text PDF